Paradigm Financial Partners, LLC Charles River Laboratories International, Inc. Transaction History

Paradigm Financial Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$204.13 - $302.4 $61,443 - $91,022	301 Added 9.51%	3,465 $795,000
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $136,186 - $193,004	533 Added 20.26%	3,164 $905,000
Q4 2021 Feb 18, 2022	SELL	$351.38 - $448.68 $5.6 Million - $7.15 Million	-15,926 Reduced 85.82%	2,631 $991,000
Q4 2021 Feb 10, 2022	BUY	$351.38 - $448.68 $5.52 Million - $7.04 Million	15,699 Added 549.3%	18,557 $6.99 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $61,112 - $75,161	164 Added 6.09%	2,858 $1.19 Million
Q2 2021 Aug 12, 2021	BUY	$294.17 - $371.65 $255,339 - $322,592	868 Added 47.54%	2,694 $997,000
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $83,389 - $100,026	334 Added 22.39%	1,826 $529,000
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $64,824 - $73,765	292 Added 24.33%	1,492 $393,000
Q3 2020 Nov 10, 2020	BUY	$175.56 - $226.45 $210,672 - $271,740	1,200 New	1,200 $272,000

691

52M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Paradigm Financial Partners, LLC with notifications on news.